NCT Number: NCT00167921
Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with Premarin® oral tablets in postmenopausal women with atrophic vaginitis.
Looking for future studies?
Notify MeKey information
Conditions
Age range
45 year–80 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 1
Primary location
Miami, Florida, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Generally healthy postmenopausal women.
- Intact uterus.
- Clinical diagnosis of moderate to severe atrophic vaginitis.
Treatment and study plan
Premarin® oral tablets
DrugPrimary outcomes
-
To characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with oral Premarin® tablets in postmenopausal women with atrophic vaginitis.
Secondary outcomes
-
To estimate the systemic exposure in postmenopausal women taking a typical regimen.
Sponsors and collaborators
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Registry information
Official study title
A Multiple-Dose, Comparative Bioavailability Study of Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Postmenopausal Women With Atrophic Vaginitis.
Important dates
- Study start
- 2005
- First posted
- Sep 14, 2005
- Registry last updated
- May 28, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy
NCT07346287
Atrophic Vaginitis, Female Urogenital Diseases
Laguna Hills, California, United States
View Trial DetailsEvaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy
NCT05058313
Atrophic Vaginitis, Female Urogenital Diseases
Nîmes, France
View Trial DetailsSerum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
NCT00984399
Atrophic Vaginitis, Breast Cancer
Basking Ridge, New Jersey, United States
View Trial DetailsEvaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions
NCT04219605
Atrophic Vaginitis, Bacterial Infections
Jerusalem, Israel
View Trial Details